However, alteration of the catalytic activity and regulators of PP2 A and reduction of PP2 A are implicated in the pathogenesis of AD by increasing of amyloidogenesis and tau protein hyperphosphorylation and impairment of synaptic plasticity (Sontag and Sontag 2014). This evidence concerns the gene XPNPEP2 and Alzheimer disease.